Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (85309)	2/29/2000 10:13:00 AM
From: Jenna	Read Replies (4) \| Respond to of 120523

HATH is moving like a geyser..This is now my fifth post on HATH. Something is going on with #10 yesterday's watch list.. a very unusual amount of big block go through daily. 14 already this morning and I called this AFTER it had hit a 52 week high and its still moving up. Also don't give up if you miss one leg up in a large uptrend, just wait for a small correction and get in again.. Both MCKC I missed the whole first leg up and posted that I regretted dropping it from the watch list beginning of February, but I kept watching and bidding my time. ALKS is a sad story, I held it for a few months but sold well below 100 after getting in near 60. I did NOT give up after reading about its tremendous pipeline of drugs and rebought at 122. I also rebought IMCL much later than probably any of you (98) but I'm planning IMCL, and ALKS to be long term positions. In fact they have taken the places of MLNM, INCY, BGEN, SGP and AMGN from my husbands biotech portfolio. GLGC, NGEN, ABSC more or less are too volatile and expensive to hold and forget so they would make good position trades. NGEN had a correction, ABSC will probably have one shortly.. For holding longer terms I still like the cheaper ones. CELG became expensive, CEGE is nice and recheck the 25-30 from the two biotech lists I gave you in December and Early january. Some of the newer ones that show promise (more than a one day affair) is ONXX, and of course, our little Irish Rose Biotech from yesterdays watch list. Irish stocks have really performed well.